Play

Covid has taken us on a wild ride, throwing out new variants with dizzying regularity. Now officials are recommending the new bivalent vaccines to shore up our immunity against currently circulating strains of Covid. Anna Durbin, an infectious disease expert …

When should you get the new bivalent Covid vaccine? Elizabeth Tracey reports Read more »

Play

You may have already had two Covid vaccines plus boosters, and now are not feeling much urgency to get a new bivalent vaccine. Anna Durbin, an infectious disease expert at Johns Hopkins, says the genetics of today’s circulating strains are …

The new bivalent Covid vaccines should help with a fall/winter surge, Elizabeth Tracey reports Read more »

Play

Climate change is helping diseases like malaria and dengue fever, usually associated with warmer climates, spread further around the globe. Such dynamics may render a new vaccine against malaria, even though it only prevents a minority of infections, very important. …

As malaria spreads along with expanding mosquito territory, a new vaccine may help, Elizabeth Tracey reports Read more »

Play

Trying to understand vaccine hesitancy looms large as many infectious disease experts fear a fall surge of Covid. Anna Durbin, an infectious disease expert at Johns Hopkins, says a look at what happened with the early Covid vaccines is informative. …

Why are so many people choosing not to get the most recent Covid booster? Elizabeth Tracey reports Read more »

Play

Malaria is a scourge worldwide, spread by mosquitoes. And with climate change, the range of these mosquitoes is expanding, likely bringing malaria to a location near you. Good news then that a vaccine is finally available. Infectious disease expert Anna …

A newly approved vaccine may finally make a dent in malaria, Elizabeth Tracey reports Read more »

Play

A blood marker called prostasin seems to link both one’s risk to develop diabetes and the risk of dying from cancer. How might these be linked? William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, offers his interpretation. …

How might cancer and diabetes be linked? Elizabeth Tracey reports Read more »

Play

Prostasin is the name of a blood marker that seems to be associated with someone’s risk of developing diabetes and perhaps also to the risk of dying from cancer. Kimmel Cancer Center director William Nelson at Johns Hopkins, says the …

Can a new blood marker predict who might develop diabetes or die from cancer? Elizabeth Tracey reports Read more »